HRS 2020: Medtronic’s Pacemaker Monitoring App Proves Reliable In BlueSync Study

Results from the BlueSync Field Evaluation study demonstrated that patients who used Medtronic PLC's MyCareLink Heart mobile device app were more likely to adhere to their pacemaker remote monitoring schedule than patients who transmitted data through bedside consoles.

The MyCareLink Heart app allows patients’ own phone or tablet to relay data from Medtronic’s BlueSync technology-enabled cardiac rhythm management devices to the company’s CareLink network, removing the need for a dedicated bedside console or other remote-monitoring hardware. The US Food and Drug Administration